WallStreetZenWallStreetZen

NASDAQ: CBIO
Catalyst Biosciences Inc Stock

Open Broker Account
$0.51-0.01 (-1.92%)
Updated Sep 29, 2022
CBIO Price
$0.51
Fair Value Price
$2.91
Market Cap
$16.18M
52 Week Low
$0.35
52 Week High
$4.21
P/E
-1.98x
P/B
0.2x
P/S
10.13x
PEG
N/A
Dividend Yield
0%
Revenue
$5.53M
Earnings
-$8.47M
Gross Margin
-0.5%
Operating Margin
-153.1%
Profit Margin
-153.1%
Debt to Equity
0.06
Operating Cash Flow
-$64M
Beta
1.27
Next Earnings
Nov 10, 2022
Ex-Dividend
N/A
Next Dividend
N/A

CBIO Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CBIO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CBIO ($0.51) is undervalued by 82.33% relative to our estimate of its Fair Value price of $2.91 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CBIO ($0.51) is significantly undervalued by 82.33% relative to our estimate of its Fair Value price of $2.91 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CBIO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CBIO due diligence checks available for Premium users.

Be the first to know about important CBIO news, forecast changes, insider trades & much more!

CBIO News

Valuation

CBIO fair value

Fair Value of CBIO stock based on Discounted Cash Flow (DCF)
Price
$0.51
Fair Value
$2.91
Undervalued by
82.47%
CBIO ($0.51) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CBIO ($0.51) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CBIO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CBIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.98x
Industry
14.01x
Market
27.81x

CBIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.2x
Industry
4.39x
CBIO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CBIO's financial health

Profit margin

Revenue
$0.0
Net Income
$51.6M
Profit Margin
0%
CBIO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CBIO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$83.4M
Liabilities
$4.3M
Debt to equity
0.06
CBIO's short-term assets ($81.31M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBIO's short-term assets ($81.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBIO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CBIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.3M
Investing
$52.9M
Financing
$0.0
CBIO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CBIO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CBIO$16.18M-0.96%-1.98x0.20x
VYNT$16.23M+0.55%-0.33x0.97x
ARDS$15.93M+7.40%-0.27x-0.57x
APRE$15.87M-0.29%-0.12x-0.44x
CYCC$16.55M-3.65%-0.67x0.55x

Catalyst Biosciences Stock FAQ

What is Catalyst Biosciences's quote symbol?

NASDAQ: CBIO) Catalyst Biosciences trades on the NASDAQ under the ticker symbol CBIO. Catalyst Biosciences stock quotes can also be displayed as NASDAQ: CBIO.

If you're new to stock investing, here's how to buy Catalyst Biosciences stock.

What is the 52 week high and low for Catalyst Biosciences (NASDAQ: CBIO)?

(NASDAQ: CBIO) Catalyst Biosciences's 52-week high was $4.21, and its 52-week low was $0.35. It is currently -87.79% from its 52-week high and 46.86% from its 52-week low.

How much is Catalyst Biosciences stock worth today?

(NASDAQ: CBIO) Catalyst Biosciences currently has 31,477,053 outstanding shares. With Catalyst Biosciences stock trading at $0.51 per share, the total value of Catalyst Biosciences stock (market capitalization) is $16.18M.

Catalyst Biosciences stock was originally listed at a price of $909.30 in Apr 12, 2006. If you had invested in Catalyst Biosciences stock at $909.30, your return over the last 16 years would have been -99.94%, for an annualized return of -37.34% (not including any dividends or dividend reinvestments).

How much is Catalyst Biosciences's stock price per share?

(NASDAQ: CBIO) Catalyst Biosciences stock price per share is $0.51 today (as of Sep 29, 2022).

What is Catalyst Biosciences's Market Cap?

(NASDAQ: CBIO) Catalyst Biosciences's market cap is $16.18M, as of Oct 1, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Catalyst Biosciences's market cap is calculated by multiplying CBIO's current stock price of $0.51 by CBIO's total outstanding shares of 31,477,053.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.